This week's Fierce Drug Delivery is brought to you by Apiject.
An estimated 14 to 19 billion incremental injections will be required by year-end 2022 to vaccinate the world's population against COVID-19 while supplying related boosters and adjuvants. In response, the industry is shifting billions of syringes from routine vaccinations and therapeutics to COVID, increasing existing capacity, and building new manufacturing sites for syringes.
Yet COVID's supply chain is still expected to fall short. What is the source of this looming shortage? Is “syringe nationalism” causing export embargoes? How is the industry responding? Is it a supply chain problem?
In this webinar, three experts in pharma and global health discuss potential solutions including,
- Onshoring of production
- Increasing capacity in existing plants
- Investing in new facilities
- Need for Government funding of long-term supply chain infrastructure
- Resources and technical know-how required for production
- Need for trained local personnel to put “shots in arms”
|
| You are currently subscribed as newsletter@newslettercollector.com |
